Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic

Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic

Background During the coronavirus disease 2019 (COVID-19) pandemic, individuals especially those with chronic diseases face various problems like psychological distress. Aim To evaluate anxiety and depression among morphea patients taking immunosuppressants compared with controls during the COVID-19...

Full description

Bibliographic Details
Main Authors: Mohammad Shahidi Dadras, Zohreh Ahmadzadeh, Shima Younespour, Fahimeh Abdollahimajd
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Series:Journal of Dermatological Treatment
Subjects:
anxiety
coronavirus disease 2019
covid-19
depression
immunosuppressive treatment
sars-cov-2
Online Access:http://dx.doi.org/10.1080/09546634.2020.1819528

Internet

http://dx.doi.org/10.1080/09546634.2020.1819528

Similar Items